The pharma major also said it was now targeting $1.5 billion in savings from an ongoing group-wide cost cutting scheme, where it had previously seen savings of up to $1 billion by 2024.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/nSF9pzU
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Novartis no longer expects earnings decline at under-review Sandoz unit
https://ift.tt/q7yIZPL
No comments:
Post a Comment